Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway

Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway

Jibo Han,* Xiaowen Shi,* Zhanxiong Zheng, Bin Zhang, Fengjie Shi, Liqin Jiang, Jianjiang Xu Department of Cardiology, Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, China *These authors contributed equally to this work Introduction: Schisandrin B (SchB), the main acti...

Full description

Bibliographic Details
Main Authors: Han J, Shi X, Zheng Z, Zhang B, Shi F, Jiang L, Xu J
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Drug Design, Development and Therapy
Subjects:
Schisandrin B
Keap1
oxidative stress
angiotensin II
rat aortic endothelial cell
Online Access:https://www.dovepress.com/schisandrin-b-protects-against-angiotensin-ii-induced-endotheliocyte-d-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/schisandrin-b-protects-against-angiotensin-ii-induced-endotheliocyte-d-peer-reviewed-article-DDDT

Similar Items